By contrast, in a cohort of 95 patients with lung adenocarcinoma, TRPC3 expression as determined by mRNA levels (real-time RT-PCR) identified a group with good prognosis [182]. The gene discussed is TRPC3; the disease is lung adenocarcinoma.